S. YAPALI Et Al. , "Real life Efficay and Tolerability of Tenofovir alafanamide fumarate in patients with hepatitis B virus related cirrhosis and liver transplant recepients: a prilimanary result," AASLD 2021 congress , 2021
YAPALI, S. Et Al. 2021. Real life Efficay and Tolerability of Tenofovir alafanamide fumarate in patients with hepatitis B virus related cirrhosis and liver transplant recepients: a prilimanary result. AASLD 2021 congress .
YAPALI, S., GÖKCAN, H., Harputluoğlu, M., MELEKOĞLU ELLİK, Z., AKARSU, M., ADANIR, H., ... ARI, D.(2021). Real life Efficay and Tolerability of Tenofovir alafanamide fumarate in patients with hepatitis B virus related cirrhosis and liver transplant recepients: a prilimanary result . AASLD 2021 congress
YAPALI, SUNA Et Al. "Real life Efficay and Tolerability of Tenofovir alafanamide fumarate in patients with hepatitis B virus related cirrhosis and liver transplant recepients: a prilimanary result," AASLD 2021 congress, 2021
YAPALI, SUNA Et Al. "Real life Efficay and Tolerability of Tenofovir alafanamide fumarate in patients with hepatitis B virus related cirrhosis and liver transplant recepients: a prilimanary result." AASLD 2021 congress , 2021
YAPALI, S. Et Al. (2021) . "Real life Efficay and Tolerability of Tenofovir alafanamide fumarate in patients with hepatitis B virus related cirrhosis and liver transplant recepients: a prilimanary result." AASLD 2021 congress .
@conferencepaper{conferencepaper, author={SUNA YAPALI Et Al. }, title={Real life Efficay and Tolerability of Tenofovir alafanamide fumarate in patients with hepatitis B virus related cirrhosis and liver transplant recepients: a prilimanary result}, congress name={AASLD 2021 congress}, city={}, country={}, year={2021}}